The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

Manufacturing Site Change Supplements: Content and Submission



Document Type:
This guidance explains FDA’s current thinking regarding the following: (A) What constitutes a manufacturing site change and when you should submit a PMA supplement for a site change; (B) What documentation you should submit in a site change supplement; and (C) The general factors FDA intends to consider when determining whether to conduct an establishment inspection prior to approval of a site change supplement.

Go back

GMP Conferences by Topics